EMR
May 7, 2025 - AI Summary
Overvalued by 62.2% based on the discounted cash flow analysis.
Market cap | $74.91 Billion |
---|---|
Enterprise Value | $89.13 Billion |
Dividend Yield | $2.1075 (1.58256364045956%) |
Earnings per Share | $3.44 |
Beta | 1.27 |
Outstanding Shares | 563,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 31.3 |
---|---|
PEG | -980.23 |
Price to Sales | 4.51 |
Price to Book Ratio | 4.11 |
Enterprise Value to Revenue | 5.06 |
Enterprise Value to EBIT | 35.54 |
Enterprise Value to Net Income | 37 |
Total Debt to Enterprise | 0.18 |
Debt to Equity | 0.84 |
No data
No data